Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
CROSSMARK LOGO Buy Reprints
PDF

Translate this page into:

Observation Letters
87 (
5
); 706-708
doi:
10.25259/IJDVL_1116_20
pmid:
34379953

Induction of localized bullous pemphigoid on a young woman following a chemical peel

Department of Pathology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Hongqiao, Tianjin, China
Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Hongqiao, Tianjin, China
Corresponding author: Dr. Xiangjun Kong, Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Hongqiao, Tianjin, China. xiangjunkong00@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Gu A, Zhang L, Ma F, Kong X. Induction of localized bullous pemphigoid on a young woman following a chemical peel. Indian J Dermatol Venereol Leprol 2021;87:706-8.

Sir,

Bullous pemphigoid is a senile acquired autoimmune bullous disorder and its localized variant is rare in young adults. Several known triggering factors exist such as drugs, trauma, surgery and radiation therapy.1 Here, we report a young female who developed localized facial bullous pemphigoid following a glycolic acid chemical peel.

A 26-year-old female presented with itchy erythema and vesicles on her face since two months.The patient had history of acne vulgaris for seven years, which improved with treatment one year before her visit. To improve her skin-texture, she underwent a single session of glycolic acid chemical peeling (unknown concentration) in a local beauty salon 20 days preceding her clinical symptoms. She noticed gradual development of erythema and vesicles over her healed acne lesions. A local physician diagnosed it as impetigo and she applied mupirocin ointment for two weeks without any appreciable benefit. On cutaneous examination we observed scattered erythema and papulovesicles distributed over her cheeks, chin, root of the nose, temples and forehead [Figure 1a]. Tense, clear, fluid-filled vesicles sized 0.3–1.0 cm occupied the edge of the erythema [Figure 1b]. Nikolsky’s sign was negative. Ruptured vesicles resulted in superficial erosion and crusts. No similar lesions were observed on any other part of her body. The patient denied any exposure to photosensitive food, outdoor work, drugs, radiationor other chemicals. There was no history of photosensitivity. A family history was non-contributory. Routine biochemistry including complete metabolic panels and auto-antibody screens were within normal limits. An HIV test was non-reactive.

Figure 1a:: Frontal view of erythema and papulovesicles present over the entire face
Figure 1b:: Lateral view of tense, clear, fluid-filled vesicles with the size of 0.3–1.0 cm on the edge of the erythema

Lesional skin biopsy revealed a subepidermal bulla with intravesicular and perivascular eosinophilic and lymphocytic infiltration. [Figure 2a]. Direct immunofluorescence demonstrated linear IgG and C3 deposition along the dermo-epidermal junction [Figure 2b]. Collagen IV immunostaining confirmed its presence at the base of blister [Figure 2c]. Serum anti-BP180 and BP230 antibody titres were 6.93 U/ml and <2.00 U/ml, respectively (positive≥9). Detection of auto-antibodies against the 200 kDa protein of the dermal-epidermal junction by immunoblotting with dermal extract was negative. The histopathology and positive direct immunofluorescence suggested a diagnosis of subepidermal autoimmune bullous dermatosis. Based on the clinical presentation and laboratory test results including collagen IV immunostaining, a final diagnosis of localized bullous pemphigoid was made.

Figure 2a:: A subepidermal blister with eosinophils and neutrophils infiltration (H & E) ×200
Figure 2b:: Direct immunofluorescence revealed a strong linear deposition of IgG along the dermoepidermal junction (×100)
Figure 2c:: Blister located at the epidermal side of the dermoepidermal junction, as shown by Type IV collagen by immunohistochemical staining (×100)

We prescribed oral methylprednisolone (24mg/day) and topical tacrolimus 0.1% ointment, which resulted in complete resolution of symptoms within two weeks, without any new lesion. Subsequently, methylprednisolone was tapered to 16mg/day at four weeks and 8 mg/day at six weeks. Treatment was discontinued after complete remission of skin lesions after two months of treatment initiation. During the follow-up for one year, new rashes developed intermittently which subsided with a short course of topical tacrolimus ointment. [Figure 3].

Figure 3:: Mild hypopigmentation remained after a 1-year follow-up

Bullous pemphigoid is an acquired autoimmune bullous dermatosis, predominantly affecting elderly population (65– 75 years of age). Typical skin lesions include tense blisters or bullae on normal or erythematous skin with variable pruritus.1 In most cases, lesions involve the whole body within weeks to months. However, in rare cases, the disease is characterized by localized lesions. To the best of our knowledge, only 20 cases of localized bullous pemphigoid have been reported in young adults.2 Our young female patient presented with pruritic facial blisters for 20 days after a glycolic acid peel. We detected low serum concentration of both BP180 and BP230 specific antibodies by ELISA. Positive staining for dermo-epidermal IgG and C3 by direct immunofluorescence ruled out allergic contact dermatitis. Histopathology and positive direct immunofluorescence pattern supported a diagnosis of subepidermal autoimmune bullous dermatosis. However, normal ANA level and presence of collagen IV at the base of blister ruled out bullous lupus erythematosus and epidermolysis bullosa acquisita respectively. Absence of auto-antibodies against the 200 kDa protein of the dermalepidermal junction by immunoblotting ruled out anti-p200 pemphigoid. Furthermore, young age, unmarried status and no history of preganancy and/or use of hormone-containing medications ruled out pemphigoid gestationis. Several cases of localized bullous pemphigoid have been reported with low titres of BP180 with various atypical associations.1,3 The test results of our patient are consistent with localized type according to the diagnostic criteria for atypical bullous pemphigoid.1 The previous studies have failed to perform detailed antibody titres in such patients. Thus, levels of antibodies against BP180 and BP230 in localized variant remain unclear, while other soluble ectodomains of BP180 may play some role.

Localized bullous pemphigoid (BP) may be triggered by multiple factors1 such as trauma, radiation therapy, ultraviolet radiation, thermal or electrical burns, surgical procedures, transplants, hydrostatic forces4 and topical medicines and even photodynamic therapy.3 The exact pathogenesis remains unclear. To our best knowledge, this is the first report of localized BP induced by glycolic acid chemical peeling.

Chemical peeling or chemexfoliation aims to induce a controlled chemical injury to skin to destroy the epidermis (superficial peeling) and/or portion of dermis (medium or deep peeling). Subsequently it promotes skin regeneration and tissue remodeling. Glycolic acid is an alpha-hydroxy acid which reduces corneocyte cohesion and promotes desquamation and epidermolysis.5 It is a superficial peeling agent and widely used as an effective and safe treatment option for active acne vulgaris and post-acne scarring.6

The most common complications of glycolic acid peeling include swelling, pain, persistent erythema, pruritus, allergic reactions, folliculitis/acne, infection, herpes recurrence, hypopigmentation and hyperpigmentation, demarcation lines and scarring.7 Here, we report an unique case of glycolic acid chemical peel induced localized bullous pemphigoid. We hypothesize that chemical peeling may have altered the basement membrane antigenicity by direct and uncontrolled epidermal damage, ultimately facilitating the development of this disease. Further research is required to uncover the exact patho-mechanism of this process.

Our patient experienced complete remission of skin lesions with two months of oral methylprednisolone therapy. Our case recommends the inclusion of glycolic acid peels to the list of possible exogenous triggers for localized bullous pemphigoid.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. , , , , . Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun Rev. 2015;14:438-45.
    [CrossRef] [Google Scholar]
  2. , , , . Localized bullous pemphigoid: A case report. Ann Transl Med. 2020;8:249.
    [CrossRef] [Google Scholar]
  3. , , . Localized bullous pemphigoid induced by photodynamic therapy. PhotodermatolPhotoimmunolPhotomed. 2011;27:251-3.
    [CrossRef] [Google Scholar]
  4. , , , , . Unilateral, localized bullous pemphigoid in a patient with chronic venous stasis. JAAD Case Rep. 2018;4:162-4.
    [CrossRef] [Google Scholar]
  5. , . Chemical peels in active acne and acne scars. Clin Dermatol. 2017;35:179-82.
    [CrossRef] [Google Scholar]
  6. , . The therapeutic value of glycolic acid peels in dermatology. Indian J Dermatol Venereol Leprol. 2003;69:148-50.
    [Google Scholar]
  7. , , , . Review in peeling complications. J Cosmet Dermatol. 2017;16:319-26.
    [CrossRef] [Google Scholar]

Fulltext Views
1,033

PDF downloads
89
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections